Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
2.090
+0.040 (1.95%)
Oct 6, 2025, 4:00 PM EDT - Market closed
Spero Therapeutics Market Cap
Spero Therapeutics has a market cap or net worth of $117.62 million as of October 6, 2025. Its market cap has increased by 60.60% in one year.
Market Cap
117.62M
Enterprise Value
90.04M
1-Year Change
60.60%
Ranking
Category
Stock Price
$2.09
Market Cap Chart
Since November 2, 2017, Spero Therapeutics's market cap has decreased from $159.82M to $117.62M, a decrease of -26.41%. That is a compound annual growth rate of -3.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 117.62M | 109.45% |
| Dec 31, 2024 | 56.15M | -27.92% |
| Dec 29, 2023 | 77.91M | -13.02% |
| Dec 30, 2022 | 89.57M | -82.69% |
| Dec 31, 2021 | 517.50M | -1.83% |
| Dec 31, 2020 | 527.17M | 186.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 2, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 760.42B |
| Johnson & Johnson | 452.19B |
| AbbVie | 404.56B |
| UnitedHealth Group | 325.88B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 232.61B |